All-In Podcast

Bond crisis looming? GOP abandons DOGE, Google disrupts Search with AI, OpenAI buys Jony Ive's IO

...genetic mutations, we build targeted tests for identifying that people have them. And hopefully over time can start to build more targeted therapies like this one to go after and make the changes at specific sites to fix the the genetic mutations. Ba

All-In Podcast

Bond crisis looming? GOP abandons DOGE, Google disrupts Search with AI, OpenAI buys Jony Ive's IO

...a genetic mutation being applied to a patient in vivo in the blood for a specific target for a specific particular, treatment. I just asked Grok how many diseases are because of an a to g point mutation, And it says it's hard to estimate through the

...mutations, few mistakes in copying DNA, not a problem. So we can actually neutralize the ability for our cells turning into cancer at some point. But if I ask you to copy Mary had a little lamb 40,000,000,000,000

So that was the first way of saying, you know, you could select an embryo. You you you take some eggs outside of the womb through IVF, fertilize them, and then figure out which one you want to implant. First thing you're want you're gonna wanna do is

And then after after the nineteen nineties, after that initial chromosomal test was born, you could test for single gene disorders, so called monogenics, like hemochromatosis or sickle cell disease. That was all thirty years ago. Your listeners will

there are 10 pathways or 20 pathways, but the point is there's probably more than one. And there's a hope that there might be a hope that you have one master regulator that just is this one thing, but it's much more likely there's many. But we have t

first of all CRISPR is not broad enough when I talk about gene therapy. I'm talking much broader that gene therapy in my book includes anything where there's a gene, a therapy or a preventative, and that includes say vaccines are often dispensed as o